From: Chronic renal impairment predicts oncological outcomes in UTUC patients undergoing RNU
Univariate analysis | Effect size | 95% CI | P value | |
---|---|---|---|---|
Existing renal impairment | 1.424 | 0.893 | 2.272 | 0.138 |
Smoking history | 0.933 | 0.583 | 1.494 | 0.773 |
Age > 70 | 2.056 | 1.254 | 3.372 | 0.004 |
Female | 1.214 | 0.712 | 2.071 | 0.476 |
Charlson comorbidity score | 1.107 | 0.965 | 1.271 | 0.147 |
Significant cardiovascular disease | 1.917 | 1.13 | 3.254 | 0.016 |
pT stage (Ta/is/1 as reference) | ||||
 T2 | 3.16 | 1.433 | 6.966 | 0.004 |
 T3 | 6.028 | 3.086 | 11.772 | < 0.001 |
 T4 | 13.675 | 5.038 | 37.118 | < 0.001 |
Tumour grade (Grade 1 as reference) | ||||
 Grade 2 | 0.543 | 0.172 | 1.712 | 0.297 |
 Grade 3 | 2.587 | 1.035 | 6.465 | 0.042 |
Multifocal disease | 1.016 | 0.384 | 2.686 | 0.974 |
Variant histology | 1.177 | 0.163 | 8.509 | 0.872 |
Adjuvant chemotherapy | 3.925 | 2.183 | 7.058 | < 0.01 |
Adjuvant bladder instillation | 0.927 | 0.475 | 1.81 | 0.825 |
Previous bladder cancer | 0.71 | 0.353 | 1.427 | 0.337 |
Multivariable analysis | Effect size | 95% CI | PÂ value | |
Age > 70 | 1.769 | 0.952 | 3.288 | 0.071 |
Significant cardiovascular disease | 1.892 | 1.071 | 3.34 | 0.028 |
pT stage (Ta/is/1 as reference) | ||||
 T2 | 2.357 | 0.923 | 6.021 | 0.073 |
 T3 | 4.613 | 1.924 | 11.065 | 0.001 |
 T4 | 6.478 | 1.669 | 25.144 | 0.007 |
Tumour grading (Grade 1 as reference) | ||||
 Grade 2 | 0.306 | 0.088 | 1.065 | 0.063 |
 Grade 3 | 0.763 | 0.252 | 2.308 | 0.631 |
Adjuvant chemotherapy | 1.858 | 0.762 | 4.535 | 0.173 |